Evidence map›Paper›PMID 29748306›Full record

ArticleThe European respiratory journal2018

Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study.

Yi-Qian Sun, Ben M Brumpton, Carolina Bonilla, Sarah J Lewis, Stephen Burgess, Frank Skorpen, Yue Chen, Tom I L Nilsen, Pål Richard Romundstad, Xiao-Mei Mai

Abstract read
In one paragraph

Article in The European respiratory journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yi-Qian SunDept of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Ben M BrumptonK.G. Jebsen Center for Genetic Epidemiology, Dept of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Carolina BonillaMRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Sarah J LewisMRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
Stephen BurgessMRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
Frank SkorpenDept of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Yue ChenSchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Tom I L NilsenDept of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Pål Richard RomundstadDept of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.ORCID 0000-0003-2061-4336
Xiao-Mei MaiDept of Public Health and Nursing, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

Funding

British Heart Foundation RG/13/13/30194Medical Research Council MC_UU_00002/7Medical Research Council MR/L003120/1Wellcome Trust 204623Wellcome Trust 204623/Z/16/Z
6 · The paper itself

Abstract

We aimed to investigate potential causal associations between serum 25-hydroxyvitamin D (25(OH)D) levels and incidence of lung cancer overall and histologic types.We performed a Mendelian randomisation analysis using a prospective cohort study in Norway, including 54 580 individuals and 676 incident lung cancer cases. A 25(OH)D allele score was generated based on the vitamin D-increasing alleles rs2282679, rs12785878 and rs10741657. Hazard ratios with 95% confidence intervals for incidence of lung cancer and histologic types were estimated in relation to the allele score. The inverse-variance weighted method using summarised data of individual single nucleotide polymorphisms was applied to calculate the Mendelian randomisation estimates.The allele score accounted for 3.4% of the variation in serum 25(OH)D levels. There was no association between the allele score and lung cancer incidence overall, with HR 0.99 (95% CI 0.93-1.06) per allele score. A 25 nmol·L

Indexed as

Polymorphism, Single NucleotideAdultAgedAllelesFemaleGenetic Predisposition to DiseaseHumansIncidenceLinear ModelsLung NeoplasmsMaleMendelian Randomization AnalysisMiddle AgedNorwayProspective StudiesRegistries25-hydroxyvitamin DVitamin D

Identifiers

PMID29748306
PMCPMC7614587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.